ArticleScientific reports2025
Deep learning model for screening causes of activated partial thromboplastin time prolongation using clot waveform analysis at multiple wavelengths.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Activated partial thromboplastin time (APTT) prolongation occurs due to coagulation factor deficiencies/inhibitors, lupus anticoagulant (LA), and anticoagulant-taking, necessitating discrimination through further testing. Clot waveform analysis (CWA) can discriminate causes while measuring APTT, but conventional CWA exhibits moderate accuracy due to visual judgement and limited parameter use. We applied deep learning (DL) techniques to huge numerical data constituting clot waveforms and their first- and second-derivative curves (CWA curves) to leverage hidden features for developing an accurate classification model. We utilized a multi-wavelength detection system embedded in modern coagulometers to obtain multi-wavelength CWA curves. A convolutional neural network-based DL model was trained on 683 samples (135 hemophilic, 95 LA-positive, 99 heparin-treated, 105 warfarin-treated, and 249 direct oral anticoagulant-treated) and evaluated using 10-fold cross-validation. Conventional CWA parameters showed limited discrimination abilities (area under the curve [AUC] 0.532-0.858). DL models using single-wavelength CWA curves achieved higher performance (AUC 0.943-0.988), and multi-wavelength CWA curves further improved it (AUC 0.961-0.993) with high sensitivity (≥ 88.0%), specificity (> 92.0%), and overall accuracy (88.4%), although the performance may depend on reagents and/or analyzers. DL models using multi-wavelength CWA curves show promise as high-performance screening tools for classifying APTT prolongation causes and are best built in each laboratory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.